KMDA Stock Price History and Quote Analysis: Insights for Investors
Kamada Ltd.
Stock Price Today
Kamada Ltd. (KMDA) stock declined over -1.65%, trading at $5.36 on NASDAQ, down from the previous close of $5.45. The stock opened at $5.40, fluctuating between $5.34 and $5.44 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytopenic purpura and suppression of rhesus isoimmunization; HEPAGAM B for prevention of hepatitis B recurrence liver transplants and post-exposure prophylaxis; VARIZIG for post exposure prophylaxis of varicella; and GLASSIA for intravenous AATD. It also provides KamRho (D) IM for prophylaxis of hemolytic disease of newborns; KamRho (D) IV for immune thermobocytopunic purpura; and snake bite antiserum to treat snake bites by the vipera palaestinae and echis coloratus. In addition, the company distributes BRAMITOB to manage chronic pulmonary infection; FOSTER to treat asthma; PROVOCHOLINE for the diagnosis of bronchial airway hyperactivity; AEROBIKA, an OPEP device; RUPAFIN for Allergic rhinitis and Urticaria; IVIG for immunodeficiency-related conditions; VARITECT for chicken pox and zoster herpes; ZUTECTRA and HEPATECT CP for hepatitis B; MEGALOTECT CP for cytomegalovirus virus; RUCONEST for angioedema attacks; heparin sodium injection for thrombo-embolic disorders and prophylaxis of deep vein thrombosis and thromboembolic events; ALBUMIN for blood plasma; Factor VIII for hemophilia type A; and Factor IX for hemophilia type B. Further, it offers IXIARO for Japanese encephalitis; VIVOTIF for Salmonella Typhi; PROCYSBI for nephropathic cystinosis; LAMZEDE for alpha-mannosidosis ; and ELIGARD for prostate cancer. The company markets its products through strategic partners in the United States, as well as through distributors internationally. Kamada Ltd. has strategic partnerships with Takeda Pharmaceuticals Company Limited; PARI GmbH; and Kedrion Biopharma. The company was incorporated in 1990 and is headquartered in Rehovot, Israel.
Company Information
| Employees | 378 |
| Beta | 0.246 |
| Sales or Revenue | $144.76M |
| 5Y Sales Change% | 0.043% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
Frequently Asked Questions
Kamada Ltd. (NASDAQ: KMDA) stock price is $5.36 in the last trading session. During the trading session, KMDA stock reached the peak price of $5.44 while $5.34 was the lowest point it dropped to. The percentage change in KMDA stock occurred in the recent session was -1.65% while the dollar amount for the price change in KMDA stock was -$0.09.
The NASDAQ listed KMDA is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector. Kamada Ltd. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Ms. Shavit Beladev
Vice President of Kamada Plasma
Ms. Liron Reshef
Vice President of HR
Ms. Yifat Philip Esq.
Vice President of Legal, Gen. Counsel & Corporation Sec.
Ms. Hanni Neheman
Vice President of Marketing & Sales
Mr. Jon R. Knight
Vice President of US Commercial Operations
Mr. Chaime Orlev
Chief Financial Officer
Mr. Amir London
Chief Executive Officer
Mr. Eran Nir
Chief Operating Officer
Mr. David Tsur
Co-Founder & Deputy Chairman
Mr. Boris Gorelik
Vice President of Bus. Devel. & Strategic Programs
Ms. Ariella Raban
Vice President of HR
KMDA's closing price is 31.37% higher than its 52-week low of $4.08 where as its distance from 52-week high of $6.53 is -17.92%.
Number of KMDA employees currently stands at 378.
Official Website of KMDA is: https://www.kamada.com
KMDA could be contacted at phone 972 894 06472 and can also be accessed through its website. KMDA operates from 2 Holzman Street, Rehovot, 7670402, Israel.
KMDA stock volume for the day was 16.45K shares. The average number of KMDA shares traded daily for last 3 months was 43.07K.
The market value of KMDA currently stands at $308.09M with its latest stock price at $5.36 and 57.48M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com